Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
CLICK HERE TO SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

Daily Archives: July 4, 2022

  1. Home>
  2. 2022>
  3. July>
  4. 4
Study of the Week: Is Metabolic Syndrome a Risk Factor for Pulmonary Arterial Hypertension?
source: pixabay.com

Study of the Week: Is Metabolic Syndrome a Risk Factor for Pulmonary Arterial Hypertension?

  • Post author:James Moore
  • Post published:July 4, 2022
  • Post category:pulmonary arterial hypertension

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Is Metabolic Syndrome a Risk Factor for Pulmonary Arterial Hypertension?
PDE5 Inhibitors Could Enhance Esophageal Cancer Treatment
Photo courtesy of Towfiqu Barbhuiya on Unsplash

PDE5 Inhibitors Could Enhance Esophageal Cancer Treatment

  • Post author:Jessica Lynn
  • Post published:July 4, 2022
  • Post category:Esophageal Cancer

  In many cases, orally administered PDE5 inhibitors – such as Cialis, Levitra, and Stendra – have been used to treat erectile dysfunction. These vasodilating drugs were found to be…

Continue Reading PDE5 Inhibitors Could Enhance Esophageal Cancer Treatment
New Alzheimer’s Research Could Help with Drug Development
source: pixabay.com

New Alzheimer’s Research Could Help with Drug Development

  • Post author:Jessica Lynn
  • Post published:July 4, 2022
  • Post category:Alzheimer's disease

  The number of Alzheimer’s disease diagnoses has been rising rapidly over the last few decades. Today, an estimated 6.5 million Americans alone are living with this disease. Yet there…

Continue Reading New Alzheimer’s Research Could Help with Drug Development
Early Findings Show DS-6000 Benefits for Ovarian Cancer, RCC
mohamed_hassan / Pixabay

Early Findings Show DS-6000 Benefits for Ovarian Cancer, RCC

  • Post author:Jessica Lynn
  • Post published:July 4, 2022
  • Post category:Ovarian Cancer/Renal Cell Carcinoma

  The American Society of Clinical Oncology (ASCO) Annual Meeting (“ASCO 22”) took place this year from June 2nd through the 6th, 2022. During this Annual Meeting, stakeholders within the…

Continue Reading Early Findings Show DS-6000 Benefits for Ovarian Cancer, RCC
VBI-1901 for Glioblastoma Granted Orphan Drug Designation
Unsplash: https://unsplash.com/photos/58Z17lnVS4U

VBI-1901 for Glioblastoma Granted Orphan Drug Designation

  • Post author:Jessica Lynn
  • Post published:July 4, 2022
  • Post category:Glioblastoma

  Have you ever heard of Orphan Drug designation? In the United States, this designation is granted to drugs or biologics that intend to treat, prevent, or diagnose rare diseases…

Continue Reading VBI-1901 for Glioblastoma Granted Orphan Drug Designation
FDA Grants Orphan Drug Designation to Elamipretide for DMD
source: pixabay.com

FDA Grants Orphan Drug Designation to Elamipretide for DMD

  • Post author:Kendall Mason
  • Post published:July 4, 2022
  • Post category:Duchenne Muscular Dystrophy

The Orphan Drug designation was created to aid and hasten the development of drugs created for the treatment, diagnosis, or prevention of rare diseases. When the FDA grants this designation,…

Continue Reading FDA Grants Orphan Drug Designation to Elamipretide for DMD

Featured


Picture of Family


Metastatic Breast Cancer: Navigating Grief


Picture of Ralph Family walking


Rethinking What It Means to Live With Acromegaly


Illustration of mentor program members


The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

CLICK HERE TO SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info